[Anemia in head and neck cancers].

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Bulletin du Cancer

• Publication date

  2005-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 15932808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.

  2004cited by this paper
• Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.

  2004cited by this paper
• Human recombinant erythropoietin significantly improves tumor oxygenation independent of its effects on hemoglobin.

  2003cited by this paper
• Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.

  2003cited by this paper
• Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial.

  2003cited by this paper
• Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.

  2003cited by this paper
• Erythropoietin regulates tumour growth of human malignancies.

  2003cited by this paper
• Erythropoietin improves quality of life.

  2002cited by this paper
• The Effects of Epoetin Alfa on Transfusion Requirements in Head and Neck Cancer Patients: A Prospective, Randomized, Placebo‐Controlled Study

  2002cited by this paper
• Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.

  2001cited by this paper
• Symptomatology of anemia.

  2001cited by this paper
• Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.

  2001cited by this paper
• Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx.

  2001cited by this paper
• Erythropoietin and erythropoietin receptor expression in human cancer.

  2001cited by this paper
• Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas.

  2000cited by this paper
• Erythropoietin reduces anemia and transfusions

  1999cited by this paper
• Pre-treatment anaemia alters outcome in early squamous cell carcinoma of the larynx treated by radical radiotherapy

  1999cited by this paper
• Erythropoietin for patients undergoing radiotherapy: a pilot study.

  1999cited by this paper
• Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.

  1998cited by this paper
• Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.

  1998cited by this paper
• T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control.

  1998cited by this paper
• Factors influencing quality of life in cancer patients: anemia and fatigue.

  1998cited by this paper
• Measurement of tumor oxygenation.

  1998cited by this paper
• Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study.

  1998cited by this paper
• Anemia in cancer patients.

  1998cited by this paper
• A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

  1998cited by this paper
• Oxygenation of human tumors: the Mainz experience.

  1998cited by this paper
• Can erythropoietin improve tumor oxygenation?

  1998cited by this paper
• Identification of nonproliferating but viable hypoxic tumor cells in vivo.

  1998cited by this paper
• Variations in tumour oxygen tension (pO2) during accelerated radiotherapy of head and neck carcinoma.

  1998cited by this paper
• Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

  1997cited by this paper
• Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck.

  1997cited by this paper
• Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx.

  1997cited by this paper
• Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

  1996cited by this paper
• Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

  1996cited by this paper
• Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

  1996cited by this paper
• Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.

  1996cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.

  1995cited by this paper
• Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx.

  1995cited by this paper
• An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer.

  1995cited by this paper
• Cisplatin-associated anemia: an erythropoietin deficiency syndrome.

  1995cited by this paper
• The survival of aerobic and anoxic human glioma and melanoma cells after irradiation at ultrahigh and clinical dose rates.

  1994cited by this paper
• Oxygenation of head and neck tumors

  1993cited by this paper
• p53 is required for radiation-induced apoptosis in mouse thymocytes

  1993cited by this paper
• The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma.

  1992cited by this paper
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

  1992cited by this paper
• A multivariate study of the prognosis of oral squamous cell carcinomas. Are blood group and hemoglobin new prognostic factors?

  1991cited by this paper
• Clinical radiobiology of squamous cell carcinoma of the oropharynx.

  1991cited by this paper
• The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: based on RTOG trial #79-15.

  1989cited by this paper
• Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study.

  1989cited by this paper
• Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival.

  1986cited by this paper
• The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy

  1955cited by this paper
• The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

  1953cited by this paper

• Analysis of mutational variations in TP53 tumour suppressor gene among Pakistani head and neck cancer patients

  2024cites this paper
• Head and neck cancers: Incidence, Epidemiological Risk, and Treatment Options

  2015cites this paper
• Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia.

  2009cites this paper
• [Radio-chemotherapy in head and neck cancer (EGFR+)].

  2007cites this paper
• Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations

  2007cites this paper